- My News
- All News
- Most Popular
"We're thrilled to welcome Matt and Sarah, two esteemed industry experts, to our growing team, as well as announce Semi's well-deserved promotion," said David J. Daly, Thrive's chief executive officer. "Each one of these leaders brings extensive experience in building innovative companies and will have an invaluable impact on advancing our mission to incorporate earlier cancer detection into routine medical care."
Matt Franklin brings to Thrive more than 20 years of business, commercial and strategic marketing experience in the diagnostics, life sciences and technology industries. Most recently, Mr. Franklin was the chief business officer at ArcherDx, a molecular diagnostics company, where he was responsible for commercial, market access and business development activities. Prior to Archer, he held senior leadership roles at both Foundation Medicine and Boston Scientific. At Thrive, Mr. Franklin will be responsible for setting and executing all aspects of the company's commercial and business development strategy.
At Third Rock, Sarah Larson is responsible for human resources and also provides guidance and counsel to the firm's portfolio companies as they are building their organizational capabilities, focusing on areas of human capital, leadership development and culture creation. She has more than 20 years of experience in human resources and leadership development, as well as the building of strong corporate cultures. As a member of Thrive's board of directors, Ms. Larson will be an invaluable resource as the company scales.
Semi Trotto, a member of Thrive's founding management team, has more than 20 years of experience in human resources. She most recently served as senior vice president and head of human resources at Thrive. Since joining the company, Ms. Trotto has worked to help shape and build the Thrive organization and develop an integrated culture across the company's Cambridge and Baltimore locations. Before joining Thrive, Ms. Trotto held leadership positions in human resources at Editas Medicine, Baxalta and Bristol-Myers Squibb.
About Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. is a healthcare company focused on incorporating earlier cancer detection into routine medical care to extend and save lives. Thrive is developing CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of disease that will serve as the core of its integrated cancer information offering. CancerSEEK is designed to be administered to healthy adults during routine medical care, such as a yearly checkup, alongside existing cancer screening tools. The company was launched in 2019 by Third Rock Ventures, with funding from additional investors Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Exact Sciences and others. For more information, please visit www.thrivedetect.com.
Source: Thrive Earlier Detection Corp.
Did you like this article?